Aurobindo Pharma Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

AUROBINDO PHARMA has three hundred and eighty-one approved drugs.

There are thirteen tentative approvals on AUROBINDO PHARMA drugs.

US Patents:	0
Tradenames:	297
Ingredients:	274
NDAs:	381
Patent Litigation for Aurobindo Pharma:	See patent lawsuits for Aurobindo Pharma
PTAB Cases with Aurobindo Pharma as petitioner:	See PTAB cases with Aurobindo Pharma as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	202239-004	Sep 5, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Aurobindo Pharma Ltd	AMOXICILLIN AND CLAVULANATE POTASSIUM	amoxicillin; clavulanate potassium	TABLET;ORAL	091569-002	Jan 20, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Aurobindo Pharma Ltd	RISEDRONATE SODIUM	risedronate sodium	TABLET;ORAL	200296-001	Nov 30, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Aurobindo Pharma Usa	NITROFURANTOIN	nitrofurantoin, macrocrystalline	CAPSULE;ORAL	074967-001	Jul 9, 1997		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,105,783	See Plans and Pricing
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,444,769	See Plans and Pricing
Aurobindo Pharma Usa	MAXZIDE-25	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-003	May 13, 1988	4,444,769	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.